Soleus Capital Management’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
AIC
ACM
Soleus Capital Management's SOPH Position: Q3 2026 in Review
Soleus Capital Management reduced its SOPHiA GENETICS (SOPH) stake by 99% in Q3 2026, selling an estimated $11.2M and leaving 10,000 shares worth $83.8K. The position accounts for ﹤0.01% of the portfolio, ranked #97.
Soleus Capital Management first reported a position in SOPH in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.16M in Q1 2026. 93 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.
- Soleus Capital Management held 10,000 shares of SOPHiA GENETICS worth $83.8K as of Q3 2026.
- Soleus Capital Management sold 1,555,000 SOPHiA GENETICS shares in Q3 2026, an estimated $11.2M.
- SOPHiA GENETICS made up ﹤0.01% of Soleus Capital Management's portfolio in Q3 2026, its #97 holding.
- Soleus Capital Management first reported a position in SOPHiA GENETICS in Q1 2026 and has held it in 3 quarters since.
- Soleus Capital Management's SOPHiA GENETICS position peaked at $9.16M in Q1 2026.
- 93 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.
Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.